Living Cell Technologies Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Living Cell Technologies Ltd with three other
companies in this sector in AUSTRALIA :
Invex Therapeutics Ltd
(2021
sales of 158,785.00 Australian Dollars [US$115,228.69 ]
of which 100%
was Clinical Drug Development),
Immutep Ltd
(418,168.00 Australian Dollars [US$303,460.34 ]
of which 75%
was Cancer Immunotherapy), and
Suda Pharmaceuticals Ltd
(263,889.00 Australian Dollars [US$191,501.61 ]
).
Sales Analysis.
Living Cell Technologies Ltd reported sales of A$268,184.00 (US$194.62 thousand)
for the
fiscal
year ending
June of 2021.
This
represents
a
sharp
decrease of 51.6%
versus 2020, when the company's sales were A$553,692.00 .